口服硝酸盐补充改善慢阻肺患者心血管风险标志物:ON-BC随机对照试验
ON-BC试验为随机双盲安慰剂对照平行组研究,纳入家庭收缩压≥130 mmHg的稳定期慢阻肺患者,随机给予富硝酸盐甜菜根汁(400 mg NO3-,n=40)或去硝酸盐安慰剂(n=41)每日一次共12周。结果显示活性治疗组家庭收缩压降低4.5 mmHg,6分钟步行距离改善30.0 m,内皮功能指标RHI和AIx75亦改善。
要点
- 每日400 mg硝酸盐补充12周可降低慢阻肺患者家庭收缩压约4.5 mmHg。
- 硝酸盐补充改善6分钟步行距离及内皮功能指标RHI和AIx75。
- 富硝酸盐甜菜根汁可作为慢阻肺患者改善心血管风险Profile的膳食干预。
核心结论
- 在慢阻肺患者中,长期膳食硝酸盐补充(甜菜根汁)可持续降低血压,并与内皮功能和运动能力改善相关。
研究设计与样本
- ON-BC为随机、双盲、安慰剂对照平行组试验,纳入家庭收缩压≥130 mmHg的稳定期慢阻肺患者。
- 参与者按1:1计算机生成区组随机分配至70 mL富硝酸盐甜菜根汁(400 mg NO3-,n=40)或相同外观去硝酸盐安慰剂汁(0 mg NO3-,n=41),每日一次共12周。
- 主要终点为家庭收缩压的组间变化,次要终点包括6分钟步行距离和EndoPAT测量的内皮功能指标RHI与AIx75。
主要发现
- 与安慰剂相比,活性治疗降低家庭收缩压,Hodges-Lehmann治疗效应为-4.5(95% CI -5.9至-3.0)mmHg。
- 活性治疗改善6分钟步行距离30.0(95% CI 15.7至44.2)m,p<0.001。
- 活性治疗改善RHI 0.34(95% CI 0.03至0.63),p=0.03。
- 活性治疗改善AIx75 -7.61%(95% CI -14.3至-0.95%),p=0.026。
临床怎么用
- 对于家庭收缩压≥130 mmHg的稳定期慢阻肺患者,可考虑每日补充富硝酸盐甜菜根汁(400 mg NO3-)以改善血压和运动能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Short-term studies suggest that dietary nitrate (NO3 -) supplementation may improve the cardiovascular risk profile, lowering blood pressure (BP) and enhancing endothelial function. It is not clear if these beneficial effects are sustained and whether they apply in people with COPD, who have a worse cardiovascular profile than those without COPD. Nitrate-rich beetroot juice (NR-BRJ) is a convenient dietary source of nitrate. METHODS: The ON-BC trial was a randomised, double-blind, placebo-controlled parallel group study in stable COPD patients with home systolic BP (SBP) measurement ≥130 mmHg. Participants were randomly allocated (1:1) using computer-generated, block randomisation to either 70 mL NR-BRJ (400 mg NO3 -) (n=40) or an otherwise identical nitrate-depleted placebo juice (0 mg NO3 -) (n=41), once daily for 12 weeks. The primary end-point was between-group change in home SBP measurement. Secondary outcomes included change in 6-min walk distance (6MWD) and measures of endothelial function (reactive hyperaemia index (RHI) and augmentation index normalised to a heart rate of 75 beats·min-1 (AIx75)) using an EndoPAT device. Plasma nitrate and platelet function were also measured. RESULTS: Compared with placebo, active treatment lowered SBP (Hodges-Lehmann treatment effect -4.5 (95% CI -5.9- -3.0) mmHg), and improved 6MWD (30.0 (95% CI 15.7-44.2) m; p<0.001), RHI (0.34 (95% CI 0.03-0.63); p=0.03) and AIx75 (-7.61% (95% CI -14.3- -0.95%); p=0.026). CONCLUSIONS: In people with COPD, prolonged dietary nitrate supplementation in the form of beetroot juice produces a sustained reduction in BP, associated with an improvement in endothelial function and exercise capacity.
引用
- Alasmari AM, Alsulayyim AS, Alghamdi SM, et al. Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial. Eur Respir J. 2024. PMID: 38123239. doi:10.1183/13993003.02353-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。